Stay Updated
For all press requests, please reach out to [email protected].
News and Reports
Inside Health Policy: Third Circuit Unanimously Rejects Novartis’ Claims Against IRA
“Big pharma’s legal arguments against the Medicare Negotiation Program continue to prove baseless, and their high-priced lawyers have once again lost in court. With the first round of lower negotiated prices set to take effect in January, and the second round of drugs to be announced in the coming weeks, more than 9 million patients […]
News and Reports
Bloomberg Law: Pharma’s New Watchdog Group Seeks to Halt US Drug Price Cuts
The industry’s lobbyists also appeared to be walking a tightrope earlier this year as Trump and his team started to move more decisively against the sector than during his first term. “It’s been trying every trick in the book to roll back that progress—pouring billions into lobbying and filing lawsuits that have repeatedly failed in court,” said […]
News and Reports
Inside Health Policy: Experts: False Premise Underlies Trump’s ‘Freeloading’ Drug Cost Pitch
“A most favored nation-style approach could secure a better deal for U.S. patients, but only if it includes enforcement mechanisms to stop drug manufacturers from gaming the system or shifting costs elsewhere,” Merith Basey, executive director at Patients for Affordable Drugs (P4AD), said in a statement. P4AD shared an internal analysis with IHP that shows […]
News and Reports
Bloomberg Law: Boehringer Fails to Revive Suit Over US Drug Price Talks
The ruling is “another clear win for patients,” Merith Basey, executive director of Patients for Affordable Drugs, said in a statement. “Medicare negotiation is set to deliver lower prices to more than 9 million patients across the nation in less than six months, and the popular program is standing strong against the industry’s legal attacks,” […]
News and Reports
Fierce Healthcare: Drug price negotiation program sidesteps latest legal obstacle
“This decision marks the 10th court ruling in favor of patients and against the pharmaceutical industry’s desperate legal attacks on the overwhelmingly popular Medicare negotiation program, which in January will deliver lower prices to more than 9 million patients across the nation,” said Merith Basey, executive director for advocacy group Patients for Affordable Drugs, in […]
News and Reports
IP Watchdog: Appellate Challenges to Medicare Drug Price Negotiation Program Fail
…Patient advocacy group Patients for Affordable Drugs (P4AD), meanwhile, cheered the two decisions, calling the Second Circuit ruling “a decisive win for patients.” And P4AD Executive Director Merith Basey touted the Sixth Circuit’s decision as “the 10th court ruling in favor of patients and against the pharmaceutical industry’s desperate legal attacks on the overwhelmingly popular […]
News and Reports
Healthcare Finance: Appeals court upholds Drug Price Negotiation Program
Patients For Affordable Drugs (P4AD) said it submitted four amicus briefs on behalf of patients and signed onto seven briefs supported by Protect Our Care, Doctors for America, and Families USA to support the government’s opposition to the lawsuits. P4AD Executive Director Merith Basey said, “This decision marks the 10th court ruling in favor of […]
News and Reports
Bloomberg Law: Court Again Rejects PhRMA Suit Against US Drug Price Talks
The third ruling is another “win for patients nationwide,” Merith Basey, executive director of Patients for Affordable Drugs, said in a statement. “Pharma has been dealt three decisive blows in the last 48 hours,” Basey said. “These rulings represent a strong judicial affirmation that the Medicare Drug Price Negotiation Program is here to stay and […]